Category Archives: Press Releases

Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

Posted on December 16, 2014

Northvale, New Jersey, Tuesday, December 16, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP) today announced the continued expansion of Elite’s intellectual property protection covering the Company’s abuse deterrent technology with the issuance of a second Canadian Patent, … Continue reading →

Share
Posted in Press Releases | Comments Off on Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

ELITE PHARMACEUTICALS REPORTS SUCCESSFUL PIVOTAL BIOEQUIVALENCE STUDY FOR ABUSE-DETERRENT OXYCODONE PRODUCT ELI-201

Posted on December 3, 2014

Northvale, New Jersey, Wednesday, December 03, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP) announced today successful results from a pivotal bioequivalence (BE) study for ELI-201, Elite’s twice daily abuse-deterrent oxycodone product which utilizes Elite’s proprietary pharmacological abuse-deterrent … Continue reading →

Share
Posted in Press Releases | Comments Off on ELITE PHARMACEUTICALS REPORTS SUCCESSFUL PIVOTAL BIOEQUIVALENCE STUDY FOR ABUSE-DETERRENT OXYCODONE PRODUCT ELI-201

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015

Posted on November 14, 2014

Revenues increase by 8% Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST Northvale, New Jersey, Friday, November 14, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche … Continue reading →

Share
Posted in Press Releases | Comments Off on Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015

ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS

Posted on October 24, 2014

Northvale, New Jersey, Friday, October 24, 2014: Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, today announced key management appointments of Dr. Kenneth Smith, J.D., … Continue reading →

Share
Posted in Press Releases | Comments Off on ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS